Population
in vivo expression system for hepatitis A virus (HAV) strains, including the attenuated HM175 strain
Design
Preclinical
Authors
Loading...
VP1 cleavage efficiency by 3Cpro may underlie strain attenuation; leaves open relevance to human HAV pathogenesis or vaccines.
The study demonstrates that HAV proteinase 3Cpro catalyzes the cleavage of VP1 from its precursors, with strain-specific differences in cleavage efficiency at position 273/274.
Probst et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: